Hypocellularity and insufficient expression of angiogenic factors in implanted autologous bone marrow in patients with chronic critical limb ischemia

Heart and Vessels

Volumn 27, Issue 1, 2012, Pages 38-45

  Oda, Masato ^a   Toba, Ken ^a,b   Kato, Kiminori ^a   Ozawa, Takuya ^a   Yanagawa, Takao ^a   Ikarashi, Noboru ^a   Takayama, Tsugumi ^a   Suzuki, Tomoyasu ^a   Hanawa, Haruo ^a   Masuko, Masayoshi ^a   Kobayashi, Hironori ^a   Aizawa, Yoshifusa ^a  

^a NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Angiogenic factors; Bone marrow implantation; Critical limb ischemia; Hypoxia

Indexed keywords

ANGIOPOIETIN 1; CD34 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1; MESSENGER RNA; PLACENTAL GROWTH FACTOR; SCATTER FACTOR; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN A; ANGIOGENIC PROTEIN;

AGED; ANGIOGENESIS; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW CULTURE; CELL HYPOXIA; CELL STRUCTURE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL LIMB ISCHEMIA; DISEASE ASSOCIATION; DISEASE SEVERITY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TREATMENT OUTCOME; UPREGULATION; ADULT; ANALYSIS OF VARIANCE; AUTOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CELL CULTURE; CLINICAL TRIAL; CRITICAL ILLNESS; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; ISCHEMIA; JAPAN; LEG; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; TRANSPLANTATION; VASCULARIZATION;

ADULT; AGED; ANALYSIS OF VARIANCE; ANGIOGENIC PROTEINS; BONE MARROW TRANSPLANTATION; CELL HYPOXIA; CELLS, CULTURED; CHRONIC DISEASE; CRITICAL ILLNESS; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; ISCHEMIA; JAPAN; LOWER EXTREMITY; MALE; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; RNA, MESSENGER; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 84861110541     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-011-0125-5     Document Type: Article

References (37)

1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group (2007) Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 45 Suppl S:S5-S67
2. Mautner GC, Mautner SL, Roberts WC (1992) Amounts of coronary arterial narrowing by atherosclerotic plaque at necropsy in patients with lower extremity amputation. Am J Cardiol70:1147-1151
3. De Haro J, Acin F, Lopez-Quintana A, Florez A, Martinez-Aguilar E, Varela C (2009) Meta-analysis of randomized, controlled clinical trials in angiogenesis: gene and cell therapy in peripheral arterial disease. Heart Vessels 24:321-328
4. Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M, Walsh K, Isner JM (1998) Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 97:1114-1123
5. Morishita R, Aoki M, Hashiya N, Makino H, Yamasaki K, Azuma J, Sawa Y, Matsuda H, Kaneda Y, Ogihara T (2004) Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Hypertension 44:203-209
6. Zeng R, Chen YC, Zeng Z, Liu WQ, Liu XX, Liu R, Qiang O, Li X (2010) Different angiogenesis effect of mini-TyrRS/mini-TrpRS by systemic administration of modified siRNAs in rats with acute myocardial infarction. Heart Vessels 25:324-332
7. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967
8. Isner JM, Asahara T (1999) Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest 103:1231-1236
9. Yla-Herttuala S, Alitalo K (2003) Gene transfer as a tool to induce therapeutic vascular growth. Nat Med 9:694-701
10. Shintani S, Murohara T, Ikeda H, Ueno T, Sasaki K, Duan J, Imaizumi T (2001) Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 103:897-903
11. Subramaniyam V, Waller EK, Murrow JR, Manatunga A, Lonial S, Kasirajan K, Sutcliffe D, Harris W, Taylor WR, Alexander RW, Quyyumi AA (2009) Bone marrow mobilization with granulocyte macrophage colony-stimulating factor improves endothelial dysfunction and exercise capacity in patients with peripheral arterial disease. Am Heart J 158:53-60.e1
12. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, Amano K, Kishimoto Y, Yoshimoto K, Akashi H, Shimada K, Iwasaka T, Imaizumi T; Therapeutic Angiogenesis using Cell Transplantation (TACT) Study Investigators (2002) Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360:427-435
13. Napoli C, Farzati B, Sica V, Iannuzzi E, Coppola G, Silvestroni A, Balestrieri ML, Florio A, Matarazzo A (2008) Beneficial effects of autologous bone marrow cell infusion and antioxidants/ L-arginine in patients with chronic critical limb ischemia. Eur JCardiovasc Prev Rehabil 15:709-718
14. Bartsch T, Brehm M, Zeus T, Kögler G, Wernet P, Strauer BE (2007) Transplantation of autologous mononuclear bone marrow stem cells in patients with peripheral arterial disease (the TAMPAD study). Clin Res Cardiol 96:891-899
15. Fadini GP, Agostini C, Avogaro A (2010) Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature. Atherosclerosis 209:10-17
16. Oda M, Toba K, Ozawa T, Kato K, Yanagawa T, Ikarashi N, Takayama T, Suzuki T, Hanawa H, Fuse I, Nakata K, Narita M, Takahashi M, Aizawa Y (2010) Establishment of culturing system for ex vivo expansion of angiogenic immature erythroid cells, and its application for treatment of patients with chronic severe lower limb ischemia. J Mol Cell Cardiol 49:347-353
17. Oda M, Kato K, Toba K, Otaki K, Kitajima T, Ikarashi N, Yanagawa T, Higashimura M, Asami F, Isoda M, Ozawa T, Moriyama M, Hirono S, Okura Y, Hanawa H, Kodama M, Aizawa Y (2007) Prognostic factors for critical limb ischemia after autologous bone marrow implantation. J Cardiol 50: 235-242
18. Liguori A, Fiorito C, Balestrieri ML, Crimi E, Bruzzese G, Williams-Ignarro S, D'Amora M, Sommese L, Grimaldi V, Minucci PB, Giovane A, Farzati B, Ignarro LJ, Napoli C (2008) Functional impairment of hematopoietic progenitor cells in patients with coronary heart disease. Eur J Haematol 80:258-264
19. Toba K, Hanawa H, Fuse I, Sakaue M, Watanabe K, Uesugi Y, Higuchi W, Takahashi M, Aizawa Y (2002) Difference in CD22 molecules in human B cells and basophils. Exp Hematol 30:205-211
20. Yoshida T, Hanawa H, Toba K, Watanabe H, Watanabe R, Yoshida K, Abe S, Kato K, Kodama M, Aizawa Y (2005) Expression of immunological molecules by cardiomyocytes and inflammatory and interstitial cells in rat autoimmune myocarditis. Cardiovasc Res 68:278-288
21. Rey S, Semenza GL (2010) Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovasc Res 86:236-242
22. Wang GL, Jiang BH, Rue EA, Semenza GL (1995) Hypoxiainducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92:5510-5514
23. Fong GH (2009) Regulation of angiogenesis by oxygen sensing mechanisms. J Mol Med 87:549-560
24. Fujiyama S, Amano K, Uehira K, Yoshida M, Nishiwaki Y, Nozawa Y, Jin D, Takai S, Miyazaki M, Egashira K, Imada T, Iwasaka T, Matsubara H (2003) Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circ Res 93:980-989
25. Isner JM, Pieczek A, Schainfeld R, Blair R, Haley L, Asahara T, Rosenfield K, Razvi S, Walsh K, Symes JF (1996) Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patients with ischaemic limb. Lancet 348:370-374
26. Rajagopalan S, Mohler ER, Lederman RJ, Mendelsohn FO, Saucedo JF, Goldman CK, Blebea J, Macko J, Kessler PD, Rasmussen HS, Annex BH (2003) Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation 108:1933-1938
27. Loges S, Schmids T, Carmeliet P (2009) "Antimyeloangiogenic" therapy for cancer by inhibiting PlGF. Clin Cancer Res 15:3648-3653
28. Sacramento CB, da Silva FH, Nardi NB, Yasumura EG, Baptista-Silva JC, Beutel A, de Campos RR, de Moraes JZ, Junior HS, Samoto VY, Borojevic R, Han SW (2010) Synergistic effect of vascular endothelial growth factor and granulocyte colony-stimulating factor double gene therapy in mouse limb ischemia. J Gene Med 12:310-319
29. Moriya J, Minamino T, Tateno K, Shimizu N, Kuwabara Y, Sato Y, Saito Y, Komuro I (2009) Long-term outcome of therapeutic neovascularization using peripheral blood mononuclear cells for limb ischemia. Circ Cardiovasc Interv 2:245-254
30. Crosby JR, Kaminski WE, Schatteman G, Martin PJ, Raines EW, Seifert RA, Bowen-Pope DF (2000) Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ Res 87:728-730
31. Ozawa T, Toba K, Kato K, Minagawa S, Saigawa T, Hanawa H, Makiyama Y, Moriyama M, Honma K, Isoda M, Hasegawa G, Naito M, Takahashi M, Aizawa Y (2006) Erythroid cells play essential roles in angiogenesis by bone marrow cell implantation. J Mol Cell Cardiol 40:629-638
32. Tordjman R, Delaire S, Plouët J, Ting S, Gaulard P, Fichelson S, Roméo PH, Lemarchandel V (2001) Erythroblasts are a source of angiogenic factors. Blood 97:1968-1974
33. Saigawa T, Kato K, Ozawa T, Toba K, Makiyama Y, Minagawa S, Hashimoto S, Furukawa T, Nakamura Y, Hanawa H, Kodama M, Yoshimura N, Fujiwara H, Namura O, Sogawa M, Hayashi J, Aizawa Y (2004) Clinical application of bone marrow implantation in patients with arteriosclerosis obliterans, and the association between efficacy and the number of implanted bone marrow cells. Circ J 68:1189-1193
34. Suzuki H, Iso Y, Kusuyama T, Omori Y, Soda T, Sato T, Shoji M, Koba S, Geshi E, Katagiri T (2006) Neutrophil and erythroblast regulate the effects of bone marrow cell implantation. Eur J Clin Invest 36:65-66
35. Iso Y, Soda T, Sato T, Sato R, Kusuyama T, Omori Y, Shoji M, Koba S, Katagiri T, Kobayashi Y, Suzuki H (2010) Impact of implanted bone marrow progenitor cell composition on limb salvage after cell implantation in patients with critical limb ischemia. Atherosclerosis 209:167-172
36. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Böhm M, Nickenig G (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353:999-1007
37. De Angelis C, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, Kotzin S, Laine C, Marusic A, Overbeke AJ, Schroeder TV, Sox HC, Van Der Weyden MB; International Committee of Medical Journal Editors (2005) Clinical trial registration: astatement from the International Committee of Medical Journal Editors. Circulation 111:1337-1338